Sorriso Pharmaceuticals raises $31M
Sorriso Pharmaceuticals has closed on a $31 million series A financing round. The funds will be used to help the company advance its pipeline of novel oral antibodies to address unmet needs in immune-mediated diseases. Read More
iXCells Biotechnologies unveils initiatives to drive continued growth
iXCells Biotechnologies announced that it is implementing a cloud-based enterprise resource planning solution powered by Oracle NetSuite that will integrate workflows and create operational efficiencies. Read More
Novavax receives CMA from European Commission
Novavax announced that the European Commission has granted the company a conditional marketing authorization (CMA) for its Nuvaxovid COVID-19 vaccine for use in individuals age 18 and older. The CMA is applicable in all 27 European Union member states. Read More
NIIMBL announces 32 projects funded through the American Rescue Plan
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the U.S. that will receive funding through the American Rescue Plan. Read More
Insightful Science acquires Protein Metrics
Insightful Science has completed its transaction to acquire Protein Metrics. The acquisition expands the company's R&D value chain, and it will help resolve data analysis bottlenecks currently associated with large-scale protein studies, Insightful said. Read More
VBL Therapeutics selected for 17.5M euros in funding from EIC Accelerator
VBL Therapeutics has been selected to receive 17.5 million euros in blended funding by the European Innovation Council (EIC) Accelerator. VBL is a clinical stage biotechnology company developing therapeutics for difficult-to-treat malignant solid tumors and immune or inflammatory indications. Read More
Senti Bio, Dynamics Special Purpose Corp. combine as publicly listed company
Senti Biosciences (Senti Bio) and Dynamics Special Purpose Corp. have entered into an agreement to create a public company focused on gene circuit-engineered cell and gene therapies. Read More
Merck acquires Chord Therapeutics to expand neuroinflammatory pipeline
Merck has acquired Chord Therapeutics to expand its neurology pipeline and develop Chord's lead drug candidate, CRD1 (cladribine), for the treatment of generalized myasthenia gravis and neuromyelitis optica spectrum disorder. The acquisition also builds on Merck's existing neurology portfolio in multiple sclerosis. Read More
Benjamin Franklin Institute of Technology, Ginkgo Bioworks to develop biotech manufacturing associate degree
The Benjamin Franklin Institute of Technology has partnered with Ginkgo Bioworks to develop an associate degree in biotechnology manufacturing. The program will be offered at the Nubian Square Life Science Training Center in Boston, with additional funding available through a $100,000 grant from Kargman Family Foundation. Read More
Arrowhead to build new manufacturing and lab facilities
Arrowhead Pharmaceuticals has completed a transaction to purchase 13 acres of land in the Verona Technology Park in Verona, WI, to support the production of its investigational RNA interference medicines. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
